4.7 Review

The Role of Insulin-like Growth Factor I in Mechanisms of Resilience and Vulnerability to Sporadic Alzheimer's Disease

Related references

Note: Only part of the references are listed.
Review Cell Biology

Novel approaches to increase synaptic resilience as potential treatments for Alzheimer's disease

Andrew Q. Pham et al.

Summary: A significant proportion of cognitively normal patients with Alzheimer's disease pathology have differences in their brains that make them resilient to the disease. Recent approaches have focused on increasing synaptic resilience by targeting neurotrophic factors, protective genes, and proteins involved in dendritic spine strength. These strategies have the potential to treat Alzheimer's disease by making synapses resilient to its associated pathology, rather than targeting plaques and tangles.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2023)

Review Biochemistry & Molecular Biology

Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review

Rammohan V. Rao et al.

Summary: Alzheimer's disease is a progressive neurodegenerative disease characterized by memory loss, personality changes, and declining cognitive function. While drugs that can slow down the progression of the disease are available, there is currently no solution to prevent or reverse the cognitive decline associated with Alzheimer's disease. Recent studies have identified various factors that contribute to the progression and severity of the disease, such as diet, lifestyle, stress, sleep, nutrient deficiencies, mental health, socialization, and toxins. Increasing evidence suggests that dietary and lifestyle changes may be effective in preventing, slowing, or reversing the progression of Alzheimer's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Neurosciences

The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals

Jamie M. Walker et al.

Summary: A study found that neurofibrillary degeneration and amyloid-beta plaque deposition are normal pathological changes of aging in cognitively normal individuals, regardless of cognitive status. The study also identified the levels of normal pathological changes in cognitively normal individuals that would make them resilient or resistant to the development of Alzheimer's disease.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Neurosciences

Associations Between Insulin-Like Growth Factor-1 and Resting-State Functional Connectivity in Cognitively Unimpaired Midlife Adults

Tianqi Li et al.

Summary: This study investigated the relationship between IGF-1 levels and neural network activity in 13,235 UK Biobank participants. The findings suggest that higher IGF-1 levels are associated with increased activity in the Executive Function neural network, and the relationship between IGF-1 and network activity may be modified by sex, APOE4 genotype, and age.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Biochemistry & Molecular Biology

Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease

Fangda Leng et al.

Summary: Brain network dysfunction in Alzheimer's disease is associated with neuroinflammation, independent of A beta deposition and cortical atrophy. This study found that increased microglial activation correlated with disrupted structural and functional networks, while A beta did not, suggesting a link between neuroinflammation and systemic brain dysfunction in AD.

MOLECULAR PSYCHIATRY (2023)

Article Clinical Neurology

Traumatic brain injury and post-traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers

Michael W. Weiner et al.

Summary: The study found no significant association between TBI and/or PTSD and biomarker-defined AD. Veterans with TBI and/or PTSD had poorer cognitive status, which may be attributed to other comorbid pathologies.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology

Anna Fracassi et al.

Summary: This study discovered a group of individuals, referred to as Nondemented with AD neuropathology (NDAN), who present histopathological signs of Alzheimer's disease (AD) but remain cognitively intact. The researchers found higher levels of microglial activation and TREM2 expression in NDAN compared to AD, suggesting a more efficient removal of damaged synapses in NDAN individuals. This finding may explain the preserved cognitive function in NDAN and could provide insights for potential therapeutic strategies.

BRAIN PATHOLOGY (2023)

Article Multidisciplinary Sciences

Brain aerobic glycolysis and resilience in Alzheimer disease

Manu S. Goyal et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Review Endocrinology & Metabolism

Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis

Marisa A. A. Bickel et al.

Summary: Age-related cerebrovascular pathologies, including microvascular alterations and large vessel atherosclerosis, contribute to vascular cognitive impairment and dementia (VCID) and worsen Alzheimer's disease. Recent studies on heterochronic parabiosis models suggest that cell non-autonomous mechanisms are involved in regulating cerebrovascular aging processes. Decreased levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) in aging individuals play a significant role in the development of cerebrovascular pathologies and VCID. Understanding the role of age-related GH/IGF-1 deficiency in cerebrovascular aging is crucial for identifying interventions to promote brain health in older adults.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Clinical Neurology

Weight loss and risk of dementia in individuals with versus without obesity

Keun You Kim et al.

Summary: Using nationwide cohort data, this study explored the relationship between loss in body mass index (BMI) or waist circumference (WC) and risk of dementia, and found that BMI loss increased the risk of all-cause dementia and Alzheimer's disease in participants without obesity, but not in participants with obesity. WC loss was only associated with decreased Alzheimer's disease risk in participants with obesity.

ALZHEIMERS & DEMENTIA (2023)

Review Biochemistry & Molecular Biology

Hallmarks of neurodegenerative diseases

David M. Wilson III et al.

Summary: This article presents eight hallmarks of neurodegenerative diseases (NDDs), including pathological protein aggregation, synaptic and neuronal network dysfunction, aberrant proteostasis, cytoskeletal abnormalities, altered energy homeostasis, DNA and RNA defects, inflammation, and neuronal cell death. These hallmarks and their interactions provide a framework for studying NDDs holistically, which can be used to define pathogenic mechanisms, categorize different NDDs based on their primary hallmarks, stratify patients within a specific NDD, and design multi-targeted, personalized therapies to effectively halt NDDs.
Article Medical Laboratory Technology

The impact of different calibration matrices on the determination of insulin-like growth factor 1 by high-resolution-LC-MS in acromegalic and growth hormone deficient patients

Sebastian Simstich et al.

Summary: This study investigated the impact of different calibrator matrices on the measurement of IGF-1 by LC-MS. The results showed poor agreement between LC-MS and immunoassays, as well as variability in agreement between different immunoassays.

CLINICAL BIOCHEMISTRY (2023)

Article Neurosciences

Insulin-Like Growth Factor-1 Promotes Synaptogenesis Signaling, a Major Dysregulated Pathway in Malformation of Cortical Development, in a Rat Model

Minyoung Lee et al.

Summary: This study explores a treatment strategy for intractable epilepsy caused by malformation of cortical development (MCD) using an infant rat model. The results show significant downregulation of the synaptogenesis signaling pathway in the cortex of MCD rats. Pre-treatment with recombinant human insulin-growth factor-1 (rhIGF-1) delays the onset and reduces the number of spasms induced by N-methyl-d-aspartate (NMDA). Additionally, rhIGF1 pre-treatment leads to changes in cortical levels of glutathione (GSH), phosphocreatine (PCr), and total creatine (tCr), and upregulates the expression of cortical synaptic proteins.

MOLECULAR NEUROBIOLOGY (2023)

Review Biochemistry & Molecular Biology

The neurobiology of insulin-like growth factor I: From neuroprotection to modulation of brain states

A. Nunez et al.

Summary: After decades of research, IGF-I has been recognized as a prototypical neurotrophic factor in the field of neurobiology. However, it has been found that IGF-I is not only involved in brain development or injury response, but also plays a role in various aspects of adult brain function. It regulates the generation and function of all major types of brain cells, modulates neuronal excitability and synaptic plasticity, and intervenes in energy allocation, proteostasis, circadian cycles, mood, and cognition at different levels.

MOLECULAR PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man

Francisco Lopera et al.

Summary: This case report describes an individual heterozygous for a rare RELN-COLBOS variant that confers resilience to Alzheimer's disease. Comparison with a previously reported case revealed common features, including high amyloid plaque burden and limited Tau tangle burden. The individual carried a rare variant in the RELN gene and showed stronger activation of Dab1 and reduced Tau phosphorylation. This genetic variant suggests a role for RELN signaling in resilience to dementia.

NATURE MEDICINE (2023)

Article Neurosciences

Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience

Joe C. Udeochu et al.

Summary: Pathological hallmarks of Alzheimer's disease (AD) precede clinical symptoms by years, indicating a period of cognitive resilience before the onset of dementia. Activation of cyclic GMP-AMP synthase (cGAS) and type I interferon (IFN-I) signaling decrease this resilience, while genetic ablation of Cgas or inhibition of cGAS enhance resilience by preserving the neuronal expression of myocyte enhancer factor 2c (MEF2C). This suggests that targeting the cGAS-IFN-MEF2C axis could improve resilience against AD-related pathological insults.

NATURE NEUROSCIENCE (2023)

Article Neurosciences

Early alterations in the MCH system link aberrant neuronal activity and sleep disturbances in a mouse model of Alzheimer's disease

Sara Calafate et al.

Summary: Early AD is characterized by hippocampal hyperactivity and decreased sleep quality. The MCH system is involved in neuronal homeostasis but fails in the early stages of AD, leading to aberrant excitatory drive and sleep defects that compromise hippocampus-dependent functions.

NATURE NEUROSCIENCE (2023)

Review Clinical Neurology

Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration

Rickie Patani et al.

Summary: Therapies that prevent neuronal loss in neuroinflammation and neurodegenerative disease are still elusive. This review highlights the importance of 'omics' technologies in characterizing the functional states of reactive astrocytes in different pathological scenarios.

NATURE REVIEWS NEUROLOGY (2023)

Article Neurosciences

A dynamical systems approach for multiscale synthesis of Alzheimer's pathogenesis

Jennifer Rollo et al.

Summary: Alzheimer's disease is a complex pathology that requires non-linear dynamical systems modeling and community-wide participation to understand and predict its dynamics. A new methodology is proposed to integrate intuition and test system-level hypotheses and interventions.

NEURON (2023)

Article Nutrition & Dietetics

Longitudinal Examination of Body Mass Index and Cognitive Function in Older Adults: The HELIAD Study

Ismini Grapsa et al.

Summary: Given the increase in the aging population and prevalence of dementia, it is necessary to identify protective factors against cognitive decline. This study found that changes in BMI were associated with changes in cognition, and the impact varied depending on age.

NUTRIENTS (2023)

Article Neurosciences

Insulin-like growth factor-1 receptor controls the function of CNS-resident macrophages and their contribution to neuroinflammation

Daniela C. C. Ivan et al.

Summary: Signaling by insulin-like growth factor-1 (IGF-1) is crucial for the development and survival of the CNS. However, its role in microglia/macrophages and neuroinflammation is still unclear, resulting in contradictory reports on its therapeutic potential for diseases like MS and EAE.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Article Cell Biology

Untangling IGF-I signaling in the aging brain

Jonathan Zegarra-Valdivia et al.

Aging-US (2023)

Review Neurosciences

Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease

Shan P. Yu et al.

Summary: Stroke and late-onset Alzheimer's disease (AD) are risk factors for each other. The similarities and differences between the two in terms of pathogenesis and pathophysiology have rarely been reviewed. Recent research has found that the activation of NMDA receptors and the resulting calcium influx play an important role in both stroke and AD. Blocking extrasynaptic NMDA receptors with drugs like memantine could serve as a potential treatment option for both diseases.

MOLECULAR NEURODEGENERATION (2023)

Article Multidisciplinary Sciences

Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer's disease pathology

Yee Fun Lee et al.

Summary: Patients with Alzheimer's disease exhibit disruptions in non-rapid eye movement sleep, and a study on mouse models suggests that targeting astrocytes can improve sleep and memory disturbances.

SCIENTIFIC REPORTS (2023)

Article Multidisciplinary Sciences

Local autocrine plasticity signaling in single dendritic spines by insulin-like growth factors

Xun Tu et al.

Summary: The insulin superfamily plays crucial roles in homeostasis, neuronal plasticity, learning, and memory. In this study, the researchers found that insulin-like growth factors 1 and 2 (IGF1 and IGF2) are expressed differently in hippocampal neurons and released in an activity-dependent manner. Through the use of a new fluorescence resonance energy transfer sensor, they discovered that IGF1 triggers local autocrine activation of the IGF1 receptor (IGF1R) on the same spine and nearby dendrites, regulating the plasticity of pyramidal neurons in CA1. In CA3 neurons, IGF2 is responsible for IGF1R autocrine activation and synaptic plasticity. This research reveals the cell type-specific roles of IGF1 and IGF2 in hippocampal plasticity and a plasticity mechanism mediated by the synthesis and autocrine signaling of IGF peptides in pyramidal neurons.

SCIENCE ADVANCES (2023)

Article Clinical Neurology

Causal effect of insulin resistance on small vessel stroke and Alzheimer's disease: A Mendelian randomization analysis

Mengyuan Zhou et al.

Summary: Genetically predicted higher insulin resistance is associated with an increased risk of small vessel stroke and Alzheimer's disease, suggesting a potential causal effect of insulin resistance on these diseases. Mendelian randomization analyses provide genetic support for this association.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Neurosciences

Astrocyte-neuronal network interplay is disrupted in Alzheimer's disease mice

Justin Lines et al.

Summary: Research has found that dysfunction of astrocyte networks in AD mice may dysregulate cortical electrical activity, leading to cognitive decline.
Article Neurosciences

IGF-1 regulates astrocytic phagocytosis and inflammation through the p110 alpha isoform of PI3K in a sex-specific manner

Daniel Pinto-Benito et al.

Summary: IGF-1 regulates phagocytosis and inflammatory response of reactive astrocytes differently in males and females through the p110 alpha isoform of PI3K.
Article Biochemistry & Molecular Biology

Insulin-like growth factor I mitigates post-traumatic stress by inhibiting AMP-kinase in orexin neurons

M. Estrella Fernandez de Sevilla et al.

Summary: This study reveals that mice lacking functional insulin-like growth factor I (IGF-I) receptors in orexin neurons exhibit PTSD-like behavior and are unresponsive to the anxiolytic effects of IGF-I, while inhibition of orexin neurons improves this behavior. Systemic IGF-I treatment also ameliorates PTSD-like behavior in mice, and IGF-I modulates the GABA/Glutamate synaptic structure in orexin neurons to achieve this effect.

MOLECULAR PSYCHIATRY (2022)

Review Public, Environmental & Occupational Health

Traumatic Brain Injury and Risk of Dementia and Alzheimer's Disease: A Systematic Review and Meta-Analysis

Dongqing Gu et al.

Summary: This study examined the association between traumatic brain injury (TBI) and the subsequent occurrence of dementia and Alzheimer's disease (AD). The results showed that TBI was associated with an increased risk of dementia but not with AD. TBI with loss of consciousness was also not associated with the risk of dementia. Asian ethnicity, male gender, and participants under 65 years of age were found to be associated with a higher risk of dementia.

NEUROEPIDEMIOLOGY (2022)

Article Cell Biology

Response Facilitation Induced by Insulin-like Growth Factor-I in the Primary Somatosensory Cortex of Mice Was Reduced in Aging

Nuria Garcia-Magro et al.

Summary: Aging is associated with cognitive decline, possibly due to lower IGF-I levels. The study found reduced synaptic plasticity in S1 neurons of old mice, which could be restored by IGF-I. This suggests the potential use of IGF-I as a therapeutic tool to improve healthy aging.

CELLS (2022)

Article Clinical Neurology

Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial

Siobhan Hoscheidt et al.

Summary: The study revealed that dietary patterns in mid-life are associated with Alzheimer's disease risk, and individuals with different cognitive statuses respond differently to different diets.

ALZHEIMERS & DEMENTIA (2022)

Review Neurosciences

Traumatic Brain Injury and Risk of Neurodegenerative Disorder

Benjamin L. Brett et al.

Summary: This article reviews the evidence for traumatic brain injury (TBI) as a risk factor for neurodegenerative disorders, including Alzheimer's dementia and Parkinson's disease, in clinical and neuropathological studies. It also describes the dynamic interactions between acute response to injury and chronic processes that may be involved in TBI-related pathogenesis and progression of neurodegeneration.

BIOLOGICAL PSYCHIATRY (2022)

Article Clinical Neurology

Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease

Jaclyn M. Eissman et al.

Summary: Approximately 30% of elderly adults with Alzheimer's disease neuropathology show no cognitive decline. This study investigated the genetic factors contributing to resilience to cognitive consequences of Alzheimer's disease neuropathology in a sex-specific manner. The results identified a female-specific resilience locus and highlighted numerous sex-specific molecular pathways related to resilience. These findings suggest the importance of personalized treatment based on sex and genetic factors.

BRAIN (2022)

Article Clinical Neurology

Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging

Abdalla Z. Mohamed et al.

Summary: In this study, individuals with a history of remote traumatic brain injury (TBI) were found to have an earlier onset of cognitive impairment, greater amyloid deposition, and more pronounced cortical thinning along the Alzheimer's disease continuum.

JOURNAL OF NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Insulin-like Growth Factor I Couples Metabolism with Circadian Activity through Hypothalamic Orexin Neurons

Jaime Pignatelli et al.

Summary: The uncoupling of metabolism and circadian activity increases the risk of various pathologies. Insulin and IGF-I have been found to regulate feeding patterns and circadian rhythms. IGF-I modulates orexin neurons to align metabolism and circadian rhythms, which is essential in preventing metabolic disorders and diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Genetics & Heredity

New insights into the genetic etiology of Alzheimer's disease and related dementias

Celine Bellenguez et al.

Summary: By characterizing the genetic landscape of Alzheimer's disease and related dementias, new loci have been identified and a new genetic risk score associated with the risk of future Alzheimer's disease and dementia has been generated.

NATURE GENETICS (2022)

Review Clinical Neurology

Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes

Teresa Gomez-Isla et al.

Summary: Some individuals can accumulate high levels of Alzheimer's disease neuropathological changes without showing symptoms, which has implications for risk prediction and the development of therapeutic interventions.

NATURE REVIEWS NEUROLOGY (2022)

Review Neurosciences

Translational approaches to understanding resilience to Alzheimer's disease

Sarah M. Neuner et al.

Summary: This review explores the insights gained from both human and animal studies regarding resilience in Alzheimer's disease, and highlights future approaches to translating these insights into therapeutics.

TRENDS IN NEUROSCIENCES (2022)

Article Geriatrics & Gerontology

Insulin-like growth factor I sensitization rejuvenates sleep patterns in old mice

Jonathan A. Zegarra-Valdivia et al.

Summary: Sleep disturbances in aging mice are related to impaired IGF-I signaling onto orexin neurons, and modulation of the activity of orexin neurons in the lateral hypothalamus can improve sleep patterns.

GEROSCIENCE (2022)

Article Clinical Neurology

TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury

Fei Gao et al.

Summary: This study suggests that aberrant production of TDP-43 contributes to the exacerbation of Alzheimer's disease neuropathology and the decline in synaptic and cognitive function following traumatic brain injury.

ACTA NEUROPATHOLOGICA (2022)

Article Biochemistry & Molecular Biology

Cognitive performance protects against Alzheimer's disease independently of educational attainment and intelligence

Yang Hu et al.

Summary: This study used large-scale genome-wide association studies (GWAS) to investigate the causal relationship between educational attainment, cognitive performance, intelligence, and Alzheimer's disease (AD) through univariable and multivariable Mendelian-randomization (MR) analyses. The findings highlight the protective role of cognitive performance in AD, independently of educational attainment and intelligence.

MOLECULAR PSYCHIATRY (2022)

Article Multidisciplinary Sciences

IGF-1 receptor regulates upward firing rate homeostasis via the mitochondrial calcium uniporter

Maxim Katsenelson et al.

Summary: This study reveals that insulin-like growth factor-1 receptor (IGF-1R) is a key regulator of firing rate homeostasis in central neural circuits. At the cellular level, IGF-1R interacts with the mitochondrial calcium uniporter complex (MCUc) and modulates the reliability of burst transfer, thereby affecting firing rate homeostasis.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Review Nutrition & Dietetics

Diet in the Prevention of Alzheimer's Disease: Current Knowledge and Future Research Requirements

Oliwia Stefaniak et al.

Summary: Alzheimer's disease is a progressive brain disease that is becoming a major health issue due to the aging population. Nutrition plays a crucial role in preventing and delaying the development of the disease, with diets rich in neuroprotective nutrients such as antioxidants, B vitamins, and polyunsaturated fatty acids recommended. Studies have shown that healthy dietary patterns like the Mediterranean diet can reduce the risk of Alzheimer's disease.

NUTRIENTS (2022)

Article Neurosciences

Intramuscular insulin-like growth factor-1 gene therapy modulates reactive microglia after traumatic brain injury

Macarena Lorena Herrera et al.

Summary: Intramuscular IGF-1 gene therapy following TBI increased serum IGF1 levels, improved working memory, and reduced the number of reactive glial cells. This approach may represent a new strategy to prevent outcomes of traumatic brain injury in rats.

BRAIN RESEARCH BULLETIN (2021)

Review Neurosciences

Sleep Deprivation, a Link Between Post-Traumatic Stress Disorder and Alzheimer's Disease

Vedad Delic et al.

Summary: Alzheimer's disease affects millions of Americans, with a significant impact on caregivers. There is a bidirectional relationship between sleep deprivation and AD, with inadequate sleep potentially accelerating the progression of the disease. Patients with PTSD often experience sleep disturbances, and the relationship between sleep deprivation, AD, and PTSD has a significant impact on U.S. Veterans.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Neurosciences

Oxidative Damage and Antioxidant Response in Frontal Cortex of Demented and Nondemented Individuals with Alzheimer's Neuropathology

Anna Fracassi et al.

Summary: The correlation between the pathological features of AD and dementia has been challenged by the presence of individuals with AD neuropathology but intact cognitive function. It suggests that unknown mechanisms may be triggered to resist the detrimental effects of Aβ accumulation. The study found that AD brains exhibit a dramatic redox imbalance, while NDAN individuals show low oxidative damage, possibly due to a lack of PGC1 alpha miRNA-485-related inhibition.

JOURNAL OF NEUROSCIENCE (2021)

Review Behavioral Sciences

Relationship between Central Obesity and the incidence of Cognitive Impairment and Dementia from Cohort Studies Involving 5,060,687 Participants

Xingyao Tang et al.

Summary: The study found a higher waist circumference to be associated with an increased risk of cognitive impairment and dementia, especially in individuals over the age of 65.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

Article Cell Biology

MEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration

Scarlett J. Barker et al.

Summary: Research has shown that living in an enriched, cognitively stimulating environment is the most effective way to induce cognitive resilience. The MEF2 transcription factors have been identified as playing a crucial role in promoting cognitive resilience. Further studies are needed to explore the potential of MEF2 as biomarkers or therapeutic targets for neurodegeneration and healthy aging.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Reducing acetylated tau is neuroprotective in brain injury

Min-Kyoo Shin et al.

Summary: Traumatic brain injury induces tau acetylation, leading to neurodegeneration and neurobehavioral impairment. Protecting mice from TBI can be achieved by blocking GAPDH S-nitrosylation, inhibiting p300/CBP, or stimulating Sirtuin1. Ac-tau may serve as a therapeutic target and potential blood biomarker of TBI.
Review Endocrinology & Metabolism

Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke

Cellas A. Hayes et al.

Summary: Reduced levels of IGF-1 are associated with increased mortality, poorer functional outcomes, and worsened morbidity following ischemic stroke. Administering exogenous IGF-1 before or after ischemic insult can attenuate neurological damage and behavioral changes. Research reveals the significant role of IGF-1 in the process of stroke damage.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)

Article Neurosciences

Astrocytic IGF-IRs Induce Adenosine-Mediated Inhibitory Downregulation and Improve Sensory Discrimination

Jose Antonio Noriega-Prieto et al.

Summary: This study demonstrates that IGF-I signaling induces long-term potentiation of brain synapses in mice by activating astrocytic IGF-I receptors, resulting in changes in synaptic plasticity and animal behavior. The research reveals a novel mechanism of how IGF-I impacts cortical inhibitory synaptic plasticity and animal behavior through astrocytes.

JOURNAL OF NEUROSCIENCE (2021)

Review Multidisciplinary Sciences

Importance of circadian timing for aging and longevity

Victoria A. Acosta-Rodriguez et al.

Summary: Dietary restriction, along with drug interventions targeting nutrient-sensing gene pathways, influences energy intake and circadian rhythms to promote a healthy lifespan and mitigate negative effects of a mismatch between internal and external rhythms on organismal health.

NATURE COMMUNICATIONS (2021)

Review Cell Biology

Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration

Angelika Wieckowska-Gacek et al.

Summary: The studies suggest that an excess of saturated fatty acids and simple sugars in the diet is a known environmental risk factor of Alzheimer's disease. The systemic alterations induced by a Western diet, including metabolic changes, obesity, inflammation, may drive impairment of the blood-brain barrier and neuroinflammation, leading to neurodegeneration and cognitive impairment.

AGEING RESEARCH REVIEWS (2021)

Article Endocrinology & Metabolism

Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons

Gabriela Farias Quipildor et al.

Summary: The central administration of IGF-1 and insulin in rats leads to increased glucose infusion rate and decreased hepatic glucose production, but these effects can be prevented by blocking IGF-1R and InsR/IGF-1R hybrid receptors. Knockout studies in mice show that impairment of IGF-1R signaling in AgRP neurons affects the ability of peripheral insulin to suppress HGP, indicating a previously unappreciated role for IGF-1Rs and/or HybridRs in central insulin/IGF-1 signaling in glucose metabolism.

DIABETES (2021)

Article Geriatrics & Gerontology

Reduced Insulin-Like Growth Factor-I Effects in the Basal Forebrain of Aging Mouse

Jonathan A. Zegarra-Valdivia et al.

Summary: The study suggests that the decline in IGF-I activity in the brain with age may contribute to cognitive decline and changes in neuronal activity. The excitatory effects of IGF-I were found to decrease in old mice, with implications for age-related alterations in cortical activity.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Cell Biology

IGF-1 Haploinsufficiency Causes Age-Related Chronic Cochlear Inflammation and Increases Noise-Induced Hearing Loss

Adelaida M. Celaya et al.

Summary: This study highlights the association between IGF-1 deficiency and hearing disorders, particularly age-related hearing loss. IGF-1 haploinsufficient mice showed increased susceptibility to noise-induced hearing loss and alterations in the expression of inflammatory cytokines.

CELLS (2021)

Review Clinical Neurology

Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease

Duraisamy Kempuraj et al.

NEUROSCIENTIST (2020)

Article Clinical Neurology

Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function

Zoe Arvanitakis et al.

ANNALS OF NEUROLOGY (2020)

Review Biochemistry & Molecular Biology

Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders

Vivian Hook et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)

Article Biochemistry & Molecular Biology

Insulin-like growth factor I modulates sleep through hypothalamic orexin neurons

Jonathan A. Zegarra-Valdivia et al.

FASEB JOURNAL (2020)

Article Biochemistry & Molecular Biology

Insulin/IGF-1 Drives PERIOD Synthesis to Entrain Circadian Rhythms with Feeding Time

Priya Crosby et al.

Article Neurosciences

Serum Insulin-Like Growth Factor I Deficiency Associates to Alzheimer's Disease Co-Morbidities

Jonathan A. Zegarra-Valdivia et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Article Neurosciences

Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity

Willem Huijbers et al.

JOURNAL OF NEUROSCIENCE (2019)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Article Endocrinology & Metabolism

Melatonin induces mechanisms of brain resilience against neurodegeneration

Ruben Corpas et al.

JOURNAL OF PINEAL RESEARCH (2018)

Review Clinical Neurology

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

Steven E. Arnold et al.

NATURE REVIEWS NEUROLOGY (2018)

Review Clinical Neurology

Resistance vs resilience to Alzheimer disease Clarifying terminology for preclinical studies

Eider M. Arenaza-Urquijo et al.

NEUROLOGY (2018)

Review Clinical Neurology

Global Burden of Stroke

Mira Katan et al.

SEMINARS IN NEUROLOGY (2018)

Review Medicine, General & Internal

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link

Jaime Ramos-Cejudo et al.

EBIOMEDICINE (2018)

Article Endocrinology & Metabolism

Insulin Regulates Astrocytic Glucose Handling Through Cooperation With IGF-I

Ana M. Fernandez et al.

DIABETES (2017)

Review Neurosciences

Alzheimer's disease and diet: a systematic review

Miryam Yusufov et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)

Article Multidisciplinary Sciences

Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity

Vincenzo Sorrentino et al.

NATURE (2017)

Review Medicine, General & Internal

Post-Traumatic Stress Disorder

Arieh Shalev et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Multidisciplinary Sciences

Acute exercise does not modify brain activity and memory performance in APP/PS1 mice

Angelica Miki Stein et al.

PLOS ONE (2017)

Article Endocrinology & Metabolism

Altered cerebral insulin response in transgenic mice expressing the epsilon-4 allele of the human apolipoprotein E gene

Marie-Therese Traversy et al.

PSYCHONEUROENDOCRINOLOGY (2017)

Review Clinical Neurology

On the path to 2025: understanding the Alzheimer's disease continuum

Paul S. Aisen et al.

ALZHEIMERS RESEARCH & THERAPY (2017)

Review Geriatrics & Gerontology

Insulin-Like Growth Factor-1 and Neuroinflammation

Jose L. Labandeira-Garcia et al.

FRONTIERS IN AGING NEUROSCIENCE (2017)

Article Clinical Neurology

Dendritic spines provide cognitive resilience against Alzheimer's disease

Benjamin D. Boros et al.

ANNALS OF NEUROLOGY (2017)

Review Clinical Neurology

IGF-1: an endogenous link between traumatic brain injury and Alzheimer disease?

Ping Zheng et al.

JOURNAL OF NEUROSURGICAL SCIENCES (2017)

Review Clinical Neurology

Cerebrovascular disease in ageing and Alzheimer's disease

Seth Love et al.

ACTA NEUROPATHOLOGICA (2016)

Review Biochemistry & Molecular Biology

The Cellular Phase of Alzheimer's Disease

Bart De Strooper et al.

Article Neurosciences

IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases

Amina El Ayadi et al.

EXPERIMENTAL BRAIN RESEARCH (2016)

Article Clinical Neurology

Traumatic brain injury as a risk factor for Alzheimer's disease: current knowledge and future directions

Kristen Dams-O'Connor et al.

NEURODEGENERATIVE DISEASE MANAGEMENT (2016)

Article Medicine, Research & Experimental

Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation

Julia R. Clarke et al.

EMBO MOLECULAR MEDICINE (2015)

Article Medicine, Research & Experimental

Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo

Shannon L. Macauley et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Neurosciences

IGF-1R Reduction Triggers Neuroprotective Signaling Pathways in Spinal Muscular Atrophy Mice

Olivier Biondi et al.

JOURNAL OF NEUROSCIENCE (2015)

Review Neurosciences

Immune attack: the role of inflammation in Alzheimer disease

Frank L. Heppner et al.

NATURE REVIEWS NEUROSCIENCE (2015)

Editorial Material Clinical Neurology

Personalized Medicine for Effective Alzheimer Disease Treatment

Kenneth S. Kosik

JAMA NEUROLOGY (2015)

Article Cell Biology

Reductions in serum IGF-1 during aging impair health span

Zhenwei Gong et al.

AGING CELL (2014)

Article Clinical Neurology

Stress, PTSD, and dementia

Mark S. Greenberg et al.

ALZHEIMERS & DEMENTIA (2014)

Article Neurosciences

Insulin-Like Growth Factor-I Receptor Stimulating Activity is Associated with Dementia

Renee F. A. G. de Bruijn et al.

JOURNAL OF ALZHEIMERS DISEASE (2014)

Article Clinical Neurology

Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models

Michal Arbel-Ornath et al.

ACTA NEUROPATHOLOGICA (2013)

Article Clinical Neurology

Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology

Beatriz G. Perez-Nievas et al.

BRAIN (2013)

Article Clinical Neurology

Hypoglycemia Induces Tau Hyperphosphorylation

Chu-Wan Lee et al.

CURRENT ALZHEIMER RESEARCH (2013)

Review Multidisciplinary Sciences

Microglia: Scapegoat, Saboteur, or Something Else?

Adriano Aguzzi et al.

SCIENCE (2013)

Article Endocrinology & Metabolism

The Association Between IGF-I and Insulin Resistance A general population study in Danish adults

Nele Friedrich et al.

DIABETES CARE (2012)

Editorial Material Endocrinology & Metabolism

Diabetes in Older Adults

M. Sue Kirkman et al.

DIABETES CARE (2012)

Article Neurosciences

Reduced brain insulin-like growth factor I function during aging

Alexandre Pastoris Muller et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2012)

Review Neurosciences

The many faces of insulin-like peptide signalling in the brain

Ana M. Fernandez et al.

NATURE REVIEWS NEUROSCIENCE (2012)

Article Geriatrics & Gerontology

Frequent Cognitive Activity Compensates for Education Differences in Episodic Memory

Margie E. Lachman et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)

Article Clinical Neurology

Effects of Aerobic Exercise on Mild Cognitive Impairment A Controlled Trial

Laura D. Baker et al.

ARCHIVES OF NEUROLOGY (2010)

Review Neurosciences

Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer's disease?

Victoria E. Johnson et al.

NATURE REVIEWS NEUROSCIENCE (2010)

Article Biochemistry & Molecular Biology

A Kinase-Independent Role for Unoccupied Insulin and IGF-1 Receptors in the Control of Apoptosis

Jeremie Boucher et al.

SCIENCE SIGNALING (2010)

Article Biochemistry & Molecular Biology

Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice

Ehud Cohen et al.

Article Clinical Neurology

β-Amyloid deposition in brains of subjects with diabetes

I. Alafuzoff et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)

Article Multidisciplinary Sciences

Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle

Jae-Eun Kang et al.

SCIENCE (2009)

Article Multidisciplinary Sciences

Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice

Kishore V. Kuchibhotla et al.

SCIENCE (2009)

Article Biochemistry & Molecular Biology

The amyloidogenic potential and behavioral correlates of stress

C. Catania et al.

MOLECULAR PSYCHIATRY (2009)

Article Clinical Neurology

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon 4

Fumiko Irie et al.

ARCHIVES OF NEUROLOGY (2008)

Review Endocrinology & Metabolism

Cognitive dysfunction and diabetes mellitus

Christopher T. Kodl et al.

ENDOCRINE REVIEWS (2008)

Article Multidisciplinary Sciences

Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease

Marc Aurel Busche et al.

SCIENCE (2008)

Article Biochemistry & Molecular Biology

Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects

J. I. Trejo et al.

MOLECULAR PSYCHIATRY (2007)

Article Geriatrics & Gerontology

Inflammatory changes parallel the early stages of Alzheimer disease

A. Parachikova et al.

NEUROBIOLOGY OF AGING (2007)

Article Clinical Neurology

Education and dementia - What lies behind the association?

T. Ngandu et al.

NEUROLOGY (2007)

Article Endocrinology & Metabolism

Utility of free IGF-I measurements

Jan Frystyk

PITUITARY (2007)

Article Endocrinology & Metabolism

Normal levels of serum IGF-I: determinants and validity of current reference ranges

G. Brabant et al.

PITUITARY (2007)

Article Biochemistry & Molecular Biology

IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways

Linda Adlerz et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Multidisciplinary Sciences

Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression

Xiulian Sun et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Endocrinology & Metabolism

Central and opposing effects of IGF-I and IGF-binding protein-3 on systemic insulin action

Radhika H. Muzumdar et al.

DIABETES (2006)

Review Medicine, General & Internal

Alzheimer's disease

Kaj Blennow et al.

LANCET (2006)

Review Clinical Neurology

Involvement of oxidative stress in Alzheimer disease

Akihiko Nunomura et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Endocrinology & Metabolism

Tau is hyperphosphorylated in the insulin-like growth factor-I null brain

CM Cheng et al.

ENDOCRINOLOGY (2005)

Article Endocrinology & Metabolism

Increased risk of type 2 diabetes in Alzheimer disease

J Janson et al.

DIABETES (2004)

Article Multidisciplinary Sciences

Insulin-like growth factor I is required for vessel remodeling in the adult brain

C Lopez-Lopez et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Geriatrics & Gerontology

ApoE genotype accounts for the vast majority of AD risk and AD pathology

J Raber et al.

NEUROBIOLOGY OF AGING (2004)

Article Clinical Neurology

Stroke and the risk of Alzheimer disease

LS Honig et al.

ARCHIVES OF NEUROLOGY (2003)

Article Neurosciences

IGF-I has a direct proliferative effect in adult hippocampal progenitor cells

MAI Åberg et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2003)

Review Neurosciences

Inflammation in neurodegenerative disease - A double-edged sword

T Wyss-Coray et al.

NEURON (2002)

Article Neurosciences

Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia

Jorge Ghiso et al.

JOURNAL OF ALZHEIMERS DISEASE (2001)

Article Multidisciplinary Sciences

Insulin-like growth factor 1 regulates developing brain glucose metabolism

CM Cheng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)